Regeneron Pharmaceuticals, Inc.

LOS ANGELES CAPITAL MANAGEMENT LLC REGN

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/11/2026

Shares

100,508

Value ($000)

65,736

Weight

0.2%

2014 Q1 - 2025 Q4 (26 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/11/2026	65,736	0.2%	100,508	12/31/2025
2025 Q3	10/20/2025	53,604	0.2%	95,335	9/30/2025
2025 Q2	8/7/2025	3,890	0.0%	7,409	6/30/2025
2025 Q1	5/5/2025	4,925	0.0%	7,765	3/31/2025
2024 Q4	2/4/2025	375	0.0%	526	12/31/2024
2024 Q3	11/4/2024	1,850	0.0%	1,760	9/30/2024
2024 Q2	8/5/2024	2,662	0.0%	2,533	6/30/2024
2024 Q1	4/5/2024	1,196	0.0%	1,243	3/31/2024
2023 Q4	2/6/2024	4,694	0.0%	5,345	12/31/2023
2023 Q3	11/6/2023	576	0.0%	700	9/30/2023
2023 Q2	8/3/2023	397	0.0%	553	6/30/2023
2023 Q1	5/4/2023	32,247	0.1%	39,246	3/31/2023
2022 Q4	2/6/2023	31,943	0.2%	44,273	12/31/2022
2022 Q3	11/2/2022	37,240	0.2%	54,059	9/30/2022
2022 Q2	8/5/2022	33,883	0.2%	57,319	6/30/2022
2022 Q1	5/6/2022	39,234	0.2%	56,175	3/31/2022
2021 Q4	2/3/2022	70,032	0.3%	110,895	12/31/2021
2021 Q3	11/8/2021	20,452	0.1%	33,795	9/30/2021
2021 Q2	8/5/2021	24,686	0.1%	44,197	6/30/2021
2021 Q1	5/5/2021	12,133	0.1%	25,644	3/31/2021
2020 Q4	3/10/2021	1,707	0.0%	3,533	12/31/2020
2020 Q3	11/2/2020	6,064	0.0%	10,833	9/30/2020
2020 Q2	8/5/2020	9,717	0.0%	15,581	6/30/2020
2020 Q1	5/4/2020	12,993	0.1%	26,609	3/31/2020
2019 Q4	2/7/2020	10,179	0.1%	27,109	12/31/2019
2014 Q1	5/12/2014	7,281	0.1%	24,249	3/31/2014